Search
Moderna Shelves Plans for mRNA Drug Active Ingredient Plant in Japan Amid Current Business Climate
2025-07-18 /
Read about 0 minute
Author：小编
On July 18, Moderna announced its decision to abandon the construction of an mRNA drug active ingredient plant, a project initially led by Moderna Japan, citing a reassessment of the current business environment. Despite this, Moderna noted that the research and manufacturing facilities led by Moderna Enzymatics have been successfully completed. The company underscored that expanding its presence in Japan remains a strategic imperative and pledged to revisit the plant construction plans should the business climate improve.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
